|
Real-time Estimate
Cboe BZX
15:10:01 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 2.555 USD | -7.43% |
|
-5.97% | +54.60% |
| 08-13 | Ovid Therapeutics Reports Pipeline and Business Updates | CI |
| 08-13 | Ovid Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 539M 473M 445M 407M 760M 51.63B 765M 5.34B 2.07B 26.32B 2.02B 1.98B 85.35B | P/E 2026 * |
-7.44x | P/E 2027 * | -6.76x |
|---|---|---|---|---|---|
| Enterprise Value | 539M 473M 445M 407M 760M 51.63B 765M 5.34B 2.07B 26.32B 2.02B 1.98B 85.35B | EV / Sales 2026 * |
658x | EV / Sales 2027 * | 2,414x |
| Free-Float |
93.28% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OVID | Delayed | |
CBOE
| OVID | Real-time | |
|
Deutsche Boerse AG
| 1OT | Delayed | |
|
Börse Stuttgart
| 1OT | Delayed | |
|
Boerse Muenchen
| 1OT | Real-time | |
|
Tradegate
| 1OT | Real-time |
Last Transcript: Ovid Therapeutics Inc.
| 1 day | -7.43% | ||
| 1 week | -5.97% | ||
| Current month | -5.62% | ||
| 1 month | -10.64% | ||
| 3 months | +8.62% | ||
| 6 months | -1.18% | ||
| Current year | +54.60% |
| 1 week | 2.44 |  | 2.84 |
| 1 month | 2.44 | | 2.95 |
| Current year | 1.36 | | 3.1 |
| 1 year | 1.18 | | 3.1 |
| 3 years | 0.24 | | 4.1 |
| 5 years | 0.24 | | 4.14 |
| 10 years | 0.24 | | 15.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 2025-12-31 | |
Charles Carter
DFI | Director of Finance/CFO | 59 | 2026-07-05 |
Petra Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 60 | 2025-12-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeremy Levin
CHM | Chairman | 72 | 2014-03-31 |
Bart Friedman
BRD | Director/Board Member | 81 | 2015-11-22 |
Barbara Duncan
BRD | Director/Board Member | 61 | 2017-06-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/6/26 | Free | Chief Financial Officer | 50,000 | 0.0268% | ||
| 7/6/26 | Other | Chief Financial Officer | 450,625 | 0.2414% | ||
| 4/7/26 | Free | Director | 17,578 | 0.0133% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.43% | -5.97% | +100.00% | -32.62% | 539M | |
| +0.06% | +7.20% | +54.04% | +111.13% | 74.27B | |
| -2.29% | -1.51% | +33.30% | +75.15% | 61.21B | |
| +0.28% | +7.27% | +31.74% | +23.80% | 27.55B | |
| -1.90% | -3.42% | -18.57% | +359.23% | 26.38B | |
| -1.85% | +3.33% | +0.76% | -3.98% | 25.34B | |
| +0.57% | +3.66% | +25.59% | -9.08% | 20.84B | |
| -1.47% | +4.46% | -8.09% | +513.33% | 14.94B | |
| +1.29% | -2.49% | +163.31% | +333.06% | 15.17B | |
| -2.21% | -0.42% | +42.02% | +159.00% | 14.41B | |
| Average | -1.50% | +3.07% | +42.41% | +152.90% | 28.06B | |
| Weighted average by Cap. | -0.90% | +3.08% | +35.65% | +134.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 819K 719K 676K 618K 1.15M 78.46M 1.16M 8.12M 3.15M 40M 3.08M 3.01M 130M | 223K 196K 184K 168K 315K 21.39M 317K 2.21M 858K 10.91M 839K 820K 35.36M |
| Net income | -68.31M -59.96M -56.36M -51.53M -96.29M -6.54B -97M -677M -262M -3.34B -257M -251M -10.82B | -84.77M -74.41M -69.94M -63.95M -119M -8.12B -120M -840M -326M -4.14B -318M -311M -13.42B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-23 | US$2.525 | -8.51% | 1,719,729 |
| 26-09-22 | US$2.760 | +1.85% | 3,743,695 |
| 26-09-21 | US$2.710 | +0.74% | 1,183,519 |
| 26-09-18 | US$2.690 | -0.37% | 5,899,316 |
| 26-09-17 | US$2.700 | +0.75% | 1,985,828 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OVID Stock
Select your edition
All financial news and data tailored to specific country editions
